Researchers from the University of Pittsburgh Graduate School of Public Health have discovered that an anti-cancer drug reverses Alzheimer's disease deficits in mice. The researchers examined previously published studies on the drug bexarotene, which is approved by the FDA for the treatment of cutaneous T cell lymphoma... To continue reading, subscribe to Science Recorder today.
|Subscribe to Science Recorder and gain access to one of the web's largest collection of science news and analysis.|
|Already have an account? Sign in and begin reading Science Recorder today.|